Home > Healthcare > Medical Devices > Medical Supplies > us ophthalmic sutures market
Get a free sample of U.S. Ophthalmic Sutures Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of U.S. Ophthalmic Sutures Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Some prominent companies operating in the regional market include ;
These players are turning to various strategies for increased global presence. In June 2021, Ethicon announced the approval for the use of Ethicon Plus Sutures in surgeries within the National Health Service (NHS). These sutures provide antibacterial protection and are recommended as part of a bundle of care for preventing surgical site infection in the NHS for people that need wound closure after a surgical procedure. This recommendation represents a significant milestone for Ethicon and will help the company in strategically expanding into international markets.
Demand for natural ophthalmic sutures in the U.S. is expected to reach around USD 163 million through 2032, thanks to the adequate strength, self-degradation absorption, and non-irritating carcinogenic characteristics of the product.
U.S. market for ophthalmic sutures was valued at over USD 296 million in 2022 and is projected to observe a 5.5% CAGR through 2032, owing to the growing prevalence of eye diseases in the region.
Some prominent companies operating in the regional market include Medtronic, Mani, Corzamedical, Teleflex Incorporated, Ethicon, B Braun Melsungen AG, and DemeTECH Corporation among others.
U.S. ophthalmic sutures industry share from the hospital segment is projected to reach USD 297 million through 2032, with better healthcare infrastructure and professional aid offered by these institutions.